The activation of the Toll-like receptor 4/Myeloid differentiation primary response gene 88/Nuclear factor-kappa B (TLR4/MyD88/NF-κB) pathway is involved in the occurrence and development of HCC. Here, TLR4 is linked to hepatocellular carcinoma.